An Approach to Joint Pain in Paediatric Patients: A Comprehensive Review

Dr. Neha Khadke; Dr. Abhijit  Shinde; Dr. Sunil Natha  Mhaske; Dr. Suresh  Waydande

doi:10.46858/vimshsj.110404

Authors

Dr. Neha Khadke Department of Paediatrics, DVVPFs Medical College & Hospital, Ahmednagar-414111, Maharashtra
Dr. Abhijit Shinde
Dr. Sunil Natha Mhaske
Dr. Suresh Waydande

DOI:

https://doi.org/10.46858/vimshsj.110404

Keywords:

Paediatric joint pain, juvenile idiopathic arthritis, septic arthritis, Lyme arthritis, paediatric rheumatology, paediatric arthritis

Abstract

Joint pain in paediatric patients is a common but diagnostically challenging issue, with causes ranging from benign self-limiting conditions to serious diseases that may result in long-term disability. This review addresses a structured diagnostic approach to joint pain in children, covering infectious, inflammatory, traumatic, and neoplastic causes. Key diagnoses include septic arthritis, juvenile idiopathic arthritis (JIA), Lyme arthritis, and malignancies such as leukaemia and osteosarcoma. A detailed history and physical examination are essential for identifying underlying conditions, distinguishing benign causes from emergencies. Infectious causes require urgent consideration, especially septic arthritis, which risks rapid joint destruction. Inflammatory conditions like JIA are common chronic arthritides in children and need timely referral for rheumatologic assessment. Malignancies and traumatic causes also warrant careful attention to avoid delayed diagnosis. Laboratory investigations—including complete blood counts, inflammatory markers (ESR and CRP), and autoantibodies (ANA and RF)—help support diagnoses. Imaging studies, particularly radiography, ultrasound, and MRI, are pivotal for assessing trauma, inflammation, and marrow involvement. Targeted approaches for specific conditions, such as joint aspiration in septic arthritis and serological testing for Lyme arthritis, are discussed. Advances in biomarkers, imaging, and biologic therapies—especially TNF inhibitors and interleukin blockers—are highlighted as emerging tools in diagnosing and managing paediatric joint pain, offering promising avenues for early diagnosis and personalised care.

Downloads

Download data is not yet available.

References

Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767-78.

Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. J Rheumatol. 2004;31(2):390-2.

Nigrovic PA, Raychaudhuri S, Thompson SD. Review: Genetics and the classification of arthritis in adults and children. Arthritis Rheumatol. 2018;70(1):7-17.

Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis: A systematic review of the literature. J Bone Joint Surg Br. 2012;94(5):584-95.

Peltola H, Paakkonen M. Acute osteomyelitis in children. N Engl J Med. 2014;370(4):352-60.

Nade S. Acute septic arthritis in infancy and childhood. J Bone Joint Surg Br. 1983;65(4):234-41.

Steere AC, Strle F. Lyme borreliosis. Lancet. 2017;390(10114):1041-52.

Broliden K. Parvovirus B19 infection and joint disease. Rheumatology (Oxford). 2018;57(suppl_1):i1-i7.

Wallace CA. Update on the pharmacotherapy of juvenile idiopathic arthritis. Expert Opin Pharmacother. 2011;12(3):341-52.

Tucker LB, Menon S, Schaller JG. Pediatric systemic lupus erythematosus: Clinical manifestations and treatment. Pediatr Drugs. 2002;4(8):473-80.

Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood myositis syndromes. Rheumatology (Oxford). 2002;41(10):1173-8.

Caine DJ, DiFiori JP, Maffulli N. Physeal injuries in children’s and youth sports: Reasons for concern? Br J Sports Med. 2006;40(9):749-60.

Kessler JI, Nikizad H, Shea KG, et al. The demographics and epidemiology of osteochondritis dissecans of the knee in children and adolescents. Am J Sports Med. 2014;42(2):320-6.

Schultz KR, Bowman WP, Aledo A, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A Children’s Oncology Group study. J Clin Oncol. 2009;27(31):5175-81.

Stevenson M, Jones JG, Sarangi PP. Diagnosis of acute leukaemia in childhood. Lancet. 2002;359(9310):1646-8.

Bacci G, Ferrari S, Bertoni F, et al. Histologic response of high-grade osteosarcoma of the extremities to neoadjuvant chemotherapy. Cancer. 2003;97(12):2943-52.

Morrissey RT, Haynes J, O’Sullivan ME. Paediatric gait analysis and differential diagnosis of limb pain. Clin Pediatr. 2020;59(6):595-604.

McMahon AM, McCarthy P, Barrett MJ. Diagnostic utility of ESR and CRP in paediatric patients presenting with acute joint pain. Arch Dis Child. 2016;101(8):741-5.

Chandrashekara S, Anilkumar S. Inflammatory markers in rheumatic diseases: How consistent are they? Int J Rheum Dis. 2016;19(6):636-43.

Cassidy JT, Petty RE, Laxer RM, et al. Textbook of Pediatric Rheumatology. 6th ed. Philadelphia: Elsevier; 2011.

Brunner HI, Klein-Gitelman MS, Miller MJ, et al. Validation of the SLE Disease Activity Index in pediatric systemic lupus erythematosus. Arthritis Rheum. 2004;50(10):3167-73.

Mathews CJ, Weston VC, Jones A, et al. Bacterial septic arthritis in adults. Lancet. 2010;375(9717):846-55.

Ring D, Jupiter JB, Herndon JH. Acute septic arthritis. J Am Acad Orthop Surg. 2005;13(6):417-25.

Schmitt SK. Osteomyelitis in children: Clinical features and imaging. Infect Dis Clin North Am. 2015;29(3):557-74.

Das S, Sabharwal S. Role of ultrasound in the evaluation of paediatric hip pain. Pediatr Radiol. 2013;43(8):987-95.

Peltola H, Pääkkönen M, Kallio P, Kallio MJ. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis. 2009;48(9):1201-10.

Finzel S, Englbrecht M, Engelke K, et al. A comparative study of periarticular bone lesions in osteoarthritis, rheumatoid arthritis, and juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(3):660-7.

Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-134.

Nadelman RB, Wormser GP. Reinfection in patients with Lyme disease. Clin Infect Dis. 2007;45(8):1032-8.

Steere AC, Angelis SM. Therapy for Lyme arthritis: Strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006;54(10):3079-86.

Fletcher CDM, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002.

Sultan J, Hughes PJ, Hamblin MH. Septic arthritis in the paediatric patient: Assessment, management, and the role of ultrasound. Orthop Clin North Am. 2006;37(2):171-9.

Martinez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin as first-line therapy for invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Pediatr Infect Dis J. 2003;22(7):593-8.

Beukelman T, Patkar NM, Saag KG, et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63(4):465-82.

Ruperto N, Lovell DJ, Quartier P, et al. Abatacept in children with juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled withdrawal trial. Lancet. 2008;372(9636):383-91.

Shenoi S, Horneff G. Juvenile idiopathic arthritis: New advances in diagnosis and treatment. J Pediatr. 2016;177:15-23.

Yeo A, Mills JA, De Benedetti F, et al. Comprehensive review of juvenile idiopathic arthritis management. Pediatr Rheumatol Online J. 2018;16(1):1-10.

Scott C, Meiorin S, Filocamo G, et al. Multidisciplinary approach to juvenile idiopathic arthritis management and outcome. Ann Rheum Dis. 2010;69(3):620-8.

Lee YH, Song GG. Meta-analysis of the association between MTHFR polymorphisms and juvenile idiopathic arthritis. J Hum Genet. 2014;59(2):105-11.

Nigrovic PA, Thompson SD, Sundel RP. Biological therapy in juvenile idiopathic arthritis: Risks and benefits. Nat Rev Rheumatol. 2015;11(6):325-37.